Analytical Data
-
Gene name
VCX3A
- Application
-
Alternative Names
VCX3A; VCX3; VCX8R; VCXAVariable charge X-linked Protein 3; Variable charge Protein on X with eight repeats; VCX-8r; Variably charged Protein X-A; VCX-A
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NNX9
-
Expression Region
1-186 aa
-
AA Sequence
MSPKPRASGP PAKATEAGKR KSSSQPSPSD PKKKTTKVAK KGKAVRRGRR GKKGAATKMA AVTAPEAESG PAAPGPSDQP SQELPQHELP PEEPVSEGTQ HDPLSQESEL EEPLSQESEV EEPLSQESQV EEPLSQESEV EEPLSQESQV EEPLSQESEV EEPLSQESQV EEPLSQESEM EELPSV
-
Molecular Weight
20 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VCX3A, a member of the vacuolar protein sorting protein family, has garnered significant interest in recent years due to its potential roles in various cellular processes and its implications in disease mechanisms. Originally identified in studies related to cellular stress responses, VCX3A is speculated to function in ion transport, particularly in maintaining cellular calcium homeostasis, which is crucial for numerous physiological functions. Research has indicated that disruptions in VCX3A expression or function may be linked to neurological disorders and other conditions, highlighting the need for a deeper understanding of its structure and function. Consequently, the recombinant expression of VCX3A has become an essential area of investigation, enabling the characterization of its biochemical properties and the elucidation of its role in cellular physiology. By generating recombinant VCX3A proteins, researchers aim to explore their potential interactions with other cellular components, elucidate their structural features, and identify their functional mechanisms, thereby contributing to the development of targeted therapeutic strategies and advancing our understanding of diseases associated with VCX3A dysregulation. This research plays a crucial role in bridging the gap between basic science and clinical applications, paving the way for future studies in molecular biology and pharmacology.
